Tenofovir Disoproxil Fumarate

img

What is Lorem Ipsum?

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.

Tenofovir Disoproxil Fumarate

✅ TENOFOVIR DISOPROXIL FUMARATE (CAS 202138-50-9) – PRODUCT DESCRIPTION

Tenofovir Disoproxil Fumarate (CAS 202138-50-9) is an antiviral medication used in the treatment of HIV (Human Immunodeficiency Virus) and chronic hepatitis B. It belongs to the class of nucleotide reverse transcriptase inhibitors (NRTIs), working by inhibiting the reverse transcriptase enzyme, which is essential for the replication of the HIV virus. Tenofovir Disoproxil Fumarate is an active prodrug of tenofovir, a nucleotide analogue, and helps reduce viral load, enhance immune function, and improve the quality of life for people living with HIV and hepatitis B. It is commonly used in combination with other antiretroviral medications in HIV treatment regimens and is often part of a combination therapy for hepatitis B. This white to off-white crystalline powder is available in pharmaceutical grades (IP), ensuring high purity for use in oral tablets and capsules. We supply Tenofovir Disoproxil Fumarate to pharmaceutical manufacturers, healthcare providers, and research organizations globally, ensuring reliable and high-quality supply to USA, Malaysia, Vietnam, and Chile.

📦 Industries Used In:

  • Pharmaceuticals (treatment of HIV, hepatitis B, and antiviral therapies)

  • Healthcare (used in combination with other drugs for HIV management and chronic hepatitis B treatment)

  • Research (studies on antiviral drugs, HIV treatments, and hepatitis B management)

  • Manufacturing (production of oral tablets, capsules, and combination therapies for viral infections)

🧪 Available Grades:

  • Pharmaceutical Grade (IP)

  • Reagent Grade

  • Laboratory Grade

⚙️ Functions:

  • Nucleotide reverse transcriptase inhibitor (NRTI) used to treat HIV and hepatitis B

  • Inhibits reverse transcriptase enzyme, blocking the replication of HIV and hepatitis B

  • Reduces viral load and improves immune function in HIV patients

  • Used as part of combination therapies for HIV management and hepatitis B treatment

  • Reagent in antiviral drug research, HIV treatment studies, and hepatitis B management

🧩 Classified Under:

 

  • Pharmaceuticals

  • Antiviral Medications

  • Nucleoside Analogues

  • Active Pharmaceutical Ingredients (APIs)

  • Viral Infection Treatments

CAS Number

147127-20-6

Formula

C9H14N5O4P

Molecular Weight

287.21 g/mol

Density

1.6 g/cm³

Gravity

~1.6

Melting Point

~215°C

Partical Size

White to off-white crystalline powder
Get Quote